Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2681

Actual shortage: 255 (10%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2417 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

38 (15%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-ABACAVIR/LAMIVUDINE 300MG 600MG TABLET Resolved 2023-06-16 2023-08-17 195072
TEVA-ABACAVIR/LAMIVUDINE 300MG 600MG TABLET Resolved 2023-06-20 2023-08-18 195900
TEVA-LENOLTEC NO. 4 300MG 60MG TABLET Resolved 2017-03-17 2017-09-05 3121
TEVA-LENOLTEC NO. 4 300MG 60MG TABLET Resolved 2019-12-12 2020-01-25 101145
TEVA-LENOLTEC NO. 4 300MG 60MG TABLET Resolved 2020-06-25 2020-07-23 118928
TEVA-LENOLTEC NO. 4 300MG 60MG TABLET Resolved 2020-10-01 2020-10-22 125458
TEVA-LENOLTEC NO. 1 300MG 8MG 15MG TABLET Resolved 2019-10-31 2020-07-23 97594
TEVA-LENOLTEC NO. 1 300MG 8MG 15MG TABLET Resolved 2019-11-28 2020-05-01 99856
TEVA-RANITIDINE 300MG TABLET Resolved 2017-03-13 2020-02-13 1522
TEVA-RANITIDINE 300MG TABLET Resolved 2017-03-13 2020-02-13 1534
TEVA-GABAPENTIN 300MG CAPSULE Resolved 2017-03-17 2017-04-25 3124
ACT RANITIDINE 300MG TABLET Resolved 2017-03-17 2017-09-19 3320
TEVA-CLINDAMYCIN 300MG CAPSULE Resolved 2017-04-03 2017-10-24 5180
TEVA-QUETIAPINE XR 300MG TABLET (EXTENDED-RELEASE) Resolved 2017-04-03 2018-02-21 5223
TEVA-GABAPENTIN 300MG CAPSULE Resolved 2017-05-23 2017-09-19 10889
TEVA-GABAPENTIN 300MG CAPSULE Resolved 2018-03-16 2018-07-30 43152
ACT DILTIAZEM CD 300MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-12 2023-04-28 61340
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2020-02-13 68577
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2019-11-22 68580
TEVA-IRBESARTAN 300MG TABLET Resolved 2019-07-02 2021-09-10 88171

Showing 1701 to 1720 of 2681

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64626
RATIO-ATORVASTATIN Discontinued 2018-10-19 2018-10-19 64852
ACT CLOPIDOGREL Discontinued 2018-10-19 2018-10-19 65065
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65284
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65289
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81337
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106136
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106139
RATIO-SALBUTAMOL Discontinued 2020-02-13 2020-02-13 106151
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION 0.004% SOLUTION Discontinued 2020-01-21 2020-01-21 103788
TEVA-ECTOSONE 0.1% LOTION Discontinued 2023-12-05 2023-12-05 212526
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.375G 3G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210191
RATIO-TAMSULOSIN 0.4MG CAPSULE (SUSTAINED-RELEASE) Discontinued 2018-10-19 2018-10-19 64917

Showing 21 to 40 of 250